Editor-in-Chief: Prof. Ihtesham Ur Rehman, University of Central Lancashire, UK.
View Editorial Board
Aims & Scope
Journal of Translational Research (JTR) is taking fundamental basic science to meaningful applications through ideas and discoveries from innovation to products of therapeutic value for human patient benefit, either it is related to development of drugs, therapies, techniques and medical devices or detection and diagnosis ultimately moving from bench to the bedside or lab to patients.
Creating researchers for tomorrows’ world through translational research is crucial to improve healthcare. JTR aims to provide a platform to researchers performing research of interdisciplinary translational nature with inherent multi-disciplinarity and an ability to respond to new developments that cut across subject boundaries and having ability to translate fundamental research to clinical care. JTR aims to create impact by bringing together researchers across the disciplines with the primary aim of inspiring each other with research and discovering for a common and targeted goal.
The journal aims to publish original and review papers on diagnostic technologies that enable the earlier detection of asymptomatic disease, new anti-microbial solutions, and medical devices (for early intervention) generate ultimately leading to novel solutions and products for improving clinical care and quality life of millions.
Submitted paperers will be rigorously peer-reviewed ensuring to publish only very high quality papers are published. The Journal aims to publish innovative designing methodologically robust studies, and driving innovations that delivers solutions to everyday life challenges.
JTR is published quarterly online by Scilight Press. JTR will welcome manuscripts from anywhere in the world.
To promulgate a successful multidisciplinary approach, moving from concept of technological solutions to patients, involving scientists, engineers, and clinicians generating needlepoint and gloves off debate.
To provide a platform for “innovative solutions form lab to patients” to clinicians and non-clinicians by virtue of distinction. The journal will provide a readership to a broad range of multi-disciplinary researchers to engineers, biomaterial scientists, chemists, biologists, physicists, pharmacists, and other specialties. Industrial sector will greatly benefit as well from the publication of high quality papers at one place providing an effective interface between the university, industry, and hospitals.
Machine learning and artificial intelligence is taking science to new dimensions, hence, adopting a new approach and encouraging researchers to submit videos (real-time videos) and photos.
Providing a platform to young and upcoming researchers and a separate section for them, limiting to 4 page manuscripts.
Original papers, reviews including systematic review papers, Opinion letters, case studies, letters to editors and research letters, short communications will be published on current and trending research.
Academic publishing is evolving and a speedy peer review process will be implemented for driving innovations that delivers solutions to upcoming challenges.